Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190317 · ClinicalTrials.gov registry record
Health Information for Infected Veterans
A clinical trial of Human Immunodeficiency Virus, sponsored by VA Office of Research and Development.
- Active
- Registry status
- 123
- Enrollment target
- 8
- Study locations
NCT03190317 is a study of Human Immunodeficiency Virus that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 123 participants, below the 181-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT03190317, a study of Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- 123 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a study of My HealtheVet (MHV) use by Veterans diagnosed with Human Immunodeficiency Virus (HIV) and VA providers/staff who care for them. The investigators hope to learn and understand how MHV can improve the self-management of chronic conditions like HIV. First, the investigators will review Veteran medical records to look at the relationship between use of MHV and whether it has a positive or negative impact on the Veteran's management of HIV. Next, the investigators will interview participants to find out how MHV for self-management is used by Veterans and to find out why Veterans and providers choose to use (or not use) specific MHV tools. Lastly, the investigators will use the information found from the first two steps and create an intervention that will encourage non-MHV users to use the MHV tools that can help achieve health-related goals. Once the intervention has been developed, Veterans and providers will participate in a "cognitive walkthrough" to help the researchers test the intervention to see if it is usable, possible, and acceptable.
Conditions Studied
Interventions
- OTHER HIV-infected Veterans who use MHV
- OTHER HIV-infected Veterans who do not use MHV
- OTHER Providers and staff of HIV-infected veteran
Study Locations (8)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA San Diego Healthcare System, San Diego, CA - San Diego
Florida
- Orlando VA Medical Center, Orlando, FL - Orlando
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Maryland
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Massachusetts
- VA Bedford HealthCare System, Bedford, MA - Bedford
Nevada
- VA Southern Nevada Healthcare System, North Las Vegas, NV - Las Vegas
New York
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03190317
The ClinicalTrials.gov registry entry for NCT03190317 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 181-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (32% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 3 interventions - of which HIV-infected Veterans who use MHV is the first listed.
NCT03190317 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT03190317 about?
NCT03190317 is a clinical study titled "Health Information for Infected Veterans". This is a study of My HealtheVet (MHV) use by Veterans diagnosed with Human Immunodeficiency Virus (HIV) and VA providers/staff who care for them. The investigators hope to learn and understand how MHV can improve the self-management of chronic conditions like HIV. First, the investigators will revi...
What is the current status of trial NCT03190317?
This trial is currently active not recruiting. The enrollment target is 123 participants. The study started on 2019-06-24. Estimated completion is 2025-09-30.
What conditions does trial NCT03190317 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT03190317?
The interventions under investigation include: HIV-infected Veterans who use MHV (OTHER), HIV-infected Veterans who do not use MHV (OTHER), Providers and staff of HIV-infected veteran (OTHER).
Who is sponsoring clinical trial NCT03190317?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03190317 being conducted?
This trial has 8 study locations across California, Florida, Indiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Baricitinib for Reduction of HIV - CNS
RECRUITING · Phase 2
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RECRUITING · Phase 2
-
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
RECRUITING
-
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
RECRUITING
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.